Literature DB >> 14455153

The role of 5-fluorouracil in malignant disease.

B J KENNEDY, A THEOLOGIDES.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/therapy; URACIL/related compounds

Mesh：

Substances：

Year:  1961        PMID： 14455153     DOI： 10.7326/0003-4819-55-5-719

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  Some observations of the effects of 5-fluorouracil in the treatment of malignant tumors.

Authors:  J H WINSTON; P L MATHIS; M D EDWARDS
Journal:  J Natl Med Assoc       Date:  1962-03       Impact factor: 1.798

2.  Effects of 5-fluorouracil on exocrine glands. III. Fine structure of Brunner's glands of rats.

Authors:  C Anand; S S Han
Journal:  J Anat       Date:  1975-02       Impact factor: 2.610

3.  A light and electron microscope study of the exocrine pancreas following administration of 5-fluorouracil.

Authors:  B F Martin; R J Levin; J H Kugler
Journal:  J Anat       Date:  1969-01       Impact factor: 2.610

4.  The value of fluorinated pyrimidines in advanced malignancy.

Authors:  J J Fennelly; M X Fitzgerald
Journal:  Br J Cancer       Date:  1968-12       Impact factor: 7.640

5.  Approving cancer treatments based on endpoints other than overall survival: an analysis of historical data using the PACE Continuous Innovation Indicators™ (CII).

Authors:  Neon Brooks; Mario Campone; Silvia Paddock; Scott Shortenhaus; David Grainger; Jacqueline Zummo; Samuel Thomas; Rose Li
Journal:  Drugs Context       Date:  2017-11-15

6.  A REPORT OF THE SYSTEMIC USE OF 5-FLUOROURACIL IN THE TREATMENT OF CHINESE CANCER PATIENTS.

Authors:  D P CHAN; J H HO; A W WOO
Journal:  Br J Cancer       Date:  1964-03       Impact factor: 7.640

7.  Biocompatible DNA/5-Fluorouracil-Gemini Surfactant-Functionalized Gold Nanoparticles as Promising Vectors in Lung Cancer Therapy.

Authors:  Rosa M Giráldez-Pérez; Elia Grueso; Inmaculada Domínguez; Nuria Pastor; Edyta Kuliszewska; Rafael Prado-Gotor; Francisco Requena-Domenech
Journal:  Pharmaceutics       Date:  2021-03-21       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.